Angina after PCI
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 30-75 years; 2. Patients with angina pectoris symptoms within 12 months after PCI; 3. Patients with Qi stagnation and blood stasis syndrome based on TCM differentiation; 4. The patient signs an informed consent form, has good compliance, and cooperates with follow-up visits and re-examinations.
Exclusion criteria
Exclusion criteria: 1. Diagnosed as STEMI, or diagnosed as NSTEMI who is at high risk by Grace score; 2. Patients with congenital heart disease, severe pulmonary hypertension, malignant tumors, severe COPD; 3. Valvular disease (LVEF 1.5 times the upper limit of normal value, Cr > 1.2 times the upper limit of normal value (refer to the laboratory test normal value of the research center Scope); Other clinically significant laboratory tests are abnormal and the investigator determines that it is not suitable to be included in the group; 5. People with allergies or allergies to the test drug Xuefu Zhuyu Capsules, excipients or similar ingredients; 6. Suspected or true history of alcohol or drug abuse; 7. Pregnant or breastfeeding women or those who have planned pregnancy in the near future and are unwilling to use contraceptive measures; 8. Patients who have participated in other clinical trials within 1 month before enrollment; 9. The investigator believes that it is not appropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction rate of nitroglycerin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Angina pectoris symptom assessment;Seattle Angina Scale;Angina pectoris efficacy evaluation;Traditional Chinese Medicine symptoms;Assessment of anxiety and depression status of patients after PCI; | — |
Countries
China
Contacts
Guang'anmen Hospital, China Academy of Chinese Medical Sciences